One week left to submit your cover designs for ASPET's five journals! Selected designs will run through all of 2027, and winning images receive $250. Learn more: https://ow.ly/RLfc50Zv59f #pharmsky 🧪

Ekta Gupta, a Doctoral Researcher, is the JPET HTA for August 2026. Her research investigates how proteins inside our cells communicate to control the body's natural healing process after injury: https://doi.org/10.1016/j.jpet.2026.104950

Nominations are open for our early career division-sponsored awards! Offered by several divisions, these awards recognize outstanding contributions from rising stars in specific areas of pharmacology. 🔗 For more information, visit: https://www.aspet.org/aspet/meetings-awards/aspet-awards

There's still time to enter our journal covers contest! Send in your artwork by August 14 to have your winning cover displayed for a full year on one of ASPET's celebrated journals, and win a cash prize! Learn more: https://ow.ly/Wz3o50ZwcrY #pharmsky 🧪

This study showed the change in the organic anion transporting polypeptide OATP1B1 and 1B3 protein-protein interactions with palmitoylation status while each transporter’s expression and function unimpacted by the post-translational modification: https://ow.ly/GXGL50ZvSAj #pharmsky 🧪

Don't miss tomorrow's webinar, "Precision Peptides: New Frontiers in Pharmacology and Therapeutics." Learn more and sign up: https://ow.ly/FHUw50Zs3ls #pharmsky 🧪

In two weeks, applications open for the ASPET Editorial Fellowship Program! Fellows will work interactively with an associate editor learning elements of the editorial process, including submission, peer review, and editorial decisions. Learn more: https://ow.ly/RIXQ50ZuIEH #pharmsky 🧪

Want your artwork featured on a prestigious scientific journal for an entire year? ASPET is inviting you to submit cover designs for our five journals! Selected designs will run through all of 2027, and winning images receive $250. Learn more: https://ow.ly/FE0950Zv59i

This study reveals an elevation of CYP2E1 autoantibodies in rheumatoid arthritis patients and efficacy of a CYP2E1 inhibitor to lessen symptoms in rheumatoid arthritis animal models, indicating the role for CYP2E1 in autoimmune conditions: https://ow.ly/FlW450ZuMa1 #pharmsky 🧪

Meet the early career scientists, Dominique Farrera, Priyanka Karmokar, Lilly Bindel and Keiichiro Nakamura, who were highlighted in the July 2026 issue of The Pharmacologist. Learn what drives them and why their research is important to them: https://thepharmacologist.org/on-their-way-jul-2026/

Awathale et al. review the role of orphan receptor GPR55 in interacting with the glutamate and dopamine reward system and playing a possible role in the treatment of psychiatric disorders including schizophrenia, depression and addiction, but also in neuroprotection: https://ow.ly/3gRa50ZuLTS 🧪

Read our editor's choice to learn how preclinical data suggest that DSP-2342 may be an effective treatment for BPSD while providing cognitive improvement, and provide strong evidence to move towards human trials: https://ow.ly/X0me50ZtZBh #pharmsky 🧪

Dr. Kay Meier, reflects on the importance of scientists as public servants and advocates during challenging time for science in the United States. She highlights ASPET's science advocacy efforts and outlines initiatives to strengthen member engagement: https://ow.ly/nSq450ZtUT4

Message from the President - The Pharmacologist

We are all in this together. It is the honor of a lifetime to represent the membership of the society that has played such an important part in my own career. I intend to “pay it forward” by serving all of you.

ow.ly

Take your passion for education to the next level with the PRIME-Educator Certificate Program—a 5-month online experience designed to elevate your teaching skills and academic impact. 📅 Register by: August 19 🔗 https://www.aspet.org/aspet/education-careers/aspet-programs/prime-educator-program

This special collection seeks to profile original research in all areas associated with gene and cell-based therapeutics for neurological disorders driven by maladaptive neuroplasticity. Learn more and submit your research: https://ow.ly/UTSy50ZtBnh #pharmsky 🧪

Nominate a colleague, mentor or yourself for an ASPET Scientific Achievement Award or a Division-Sponsored Award! This is an opportunity to celebrate your peers for their contributions to pharmacology and experimental therapeutics. 🔗 https://www.aspet.org/aspet/meetings-awards/aspet-awards

📢 Announcing our next Focus on Pharmacology webinar: "Precision Peptides: New Frontiers in Pharmacology and Therapeutics." Featuring industry and academic perspectives. Learn more and sign up: https://ow.ly/7AHx50Zs3q2 #pharmsky 🧪

Veterinary pharmacology for large animals must balance effective care with animal welfare, fair competition, and public health. Responsible medication use, clear withdrawal guidelines, and stronger oversight help protect animals, people, and the food supply: https://ow.ly/3QKf50Zsi2a

Read our recent Editor's Choice, and learn how this study supports the notion that agmatine-based new therapeutics may meet an urgent need for new, nonopioid analgesic therapeutics to treat chronic pain: https://ow.ly/ua5P50Zrlok #pharmsky 🧪

Have you submitted your research to ASPET Discovery? Check out ASPET's open access journal, launched in 2025, and its rigorous computational studies that advance pharmacology, therapeutics, and drug discovery: https://www.aspetdiscovery.org/ #pharmsky 🧪

Join us for tomorrow's webinar, where our speakers will present topics ranging from undergraduate education to graduate pharmacology education, as well as curricular development, assessment, and the use of innovative technology in the classroom: https://ow.ly/gEEB50Zjnes #pharmsky 🧪

Dominique Farrera, a postdoctoral researcher, is the DMD HTA for July 2026. Her research focuses on how chronic liver disease, specifically MASH, changes the liver's ability to transport drugs and other compounds through the body: https://doi.org/10.1016/j.dmd.2026.100351.

ASPET’s Journal of Pharmacology and Experimental Therapeutics invites submissions to a new special collection entitled “Peptide-based Therapeutics for Tumor Immunomodulation.” Learn more and submit your research: https://ow.ly/kbMX50ZkJmG #pharmsky 🧪

If you are an early-career scientist with a passion for research and publishing, then you'll want to apply for the ASPET Editorial Fellowship Program. Mark your calendar: applications will open on August 17! Learn more here: https://www.aspet.org/aspet/journals/aspet-editorial-fellowship-program

Scientists, put down your microscopes and pick up your paintbrushes! ASPET is inviting you to submit cover designs for our five distinguished journals. Selected designs will run through all of 2027, and winning images receive $250. Learn more: https://ow.ly/YJ5p50ZkHf7 #pharmsky 🧪

This collection celebrates the research showcased by attendees of the 5th Transatlantic ECI GPCR Symposium, an event for early-career investigators to foster transatlantic knowledge exchange within the GPCR community. Learn more and submit your research: https://ow.ly/38Nx50ZjPrv #pharmsky 🧪

Make sure to join us for this upcoming webinar, where our speakers will present topics ranging from undergraduate education to graduate pharmacology education, as well as curricular development, assessment, and the use of innovative technology in the classroom: https://ow.ly/Ugvw50Zjnet #pharmsky 🧪

Our featured article for the Journal of Pharmacology and Experimental Therapeutics is FREE-TO-READ for the month of July. Check out this important research, handpicked by the Editor-in-Chief, and share it with your colleagues: https://ow.ly/ul6o50ZjPCw #Pharmsky 🧪

Attending #WCP2026? Make sure to visit the ASPET team at booth #17, and learn more about our journals, resources, programs, and more. We’d love to meet you!

Thank you to all who joined our effort to speak up about the OMB Proposed Rule, Regulation for Financial Assistance. You can review the comment ASPET submitted on behalf of our members here: https://ow.ly/vrwS50Znvqj OMB will review all comments received and issue a final rule in September.